Kount Receives Fourth Patent Allowance of 2011
| PR Web |
The patent paves the way for using characteristics of Domain Name Service (DNS) protocols to secure access to content on the Internet. Combining these techniques with Kount’s other patented technologies such as Multi-Layer Device Fingerprinting™ and Proxy Piercer® enable a more secure Internet experience for both merchants and users.
“Kount has always placed a high priority on developing new methods to detect, prevent and reduce the effects of fraud on both merchants and consumers,” stated
This is Kount’s fourth allowed patent in 2011. The patent application is number 13/096,673 and is entitled “Establishing Unique Sessions For DNS Subscribers.” Kount also has thirteen other pending patent applications related to cutting-edge fraud prevention and detection technologies including: system identification, data collection, credential verification, payment fraud control and risk analysis. Kount anticipates several additional applications will be filed in early 2012 to expand its intellectual property portfolio and further enhance the Kount fraud prevention and management platform.
About Kount
Kount delivers an all-in-one fraud and risk management solution for companies operating in card-not-present environments looking to simplify their fraud/risk operations and dramatically improve bottom line profitability. For each transaction, Kount Complete™ analyzes hundreds of relevant variables and activity across the globe in real-time, then delivers a highly predictive risk assessment in less than one second. Kount provides a single, turnkey fraud solution that is easy-to-implement and easy-to-use. Kount’s proprietary technology has reviewed hundreds of millions of transactions and provides maximum protection for some of the world’s best-known brands. For more information about Kount, please visit http://www.kount.com.
###
Read the full story at http://www.prweb.com/releases/2011/12/prweb9068832.htm
| Copyright: | (c) 2011 PRWEB.COM Newswire |
| Wordcount: | 340 |


TALON THERAPEUTICS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits
Advisor News
- The conversation almost no advisor is having yet
- Why advisors should offer retirement-longevity planning
- A hybrid approach outperforms the 4% Rule, researchers find
- The missing piece in most retirement plans
- Clients are bringing TikTok insurance advice into advisor meetings
More Advisor NewsAnnuity News
- Industry pushes back on linking ‘financial strength’ to annuity illustrations
- Sammons Enterprises & Sammons Financial Group Respond to Reports
- The Manhattan Life Insurance Company Acquires Union Security Life Insurance Company of New York
- Cayman Islands premier to meet with U.S. reinsurance regulators
- Investigation finds deceptive sales, churning of annuities targeting postal workers
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Americans without children are less confident about retirement, Allianz finds
- The conversation almost no advisor is having yet
- DELAWARE INSURANCE DEPARTMENT DETAILS REVIEW OF BRIGHTHOUSE ACQUISITION
- Sammons Enterprises & Sammons Financial Group Respond to Reports
- Court losses bring Greg Lindberg fraud victims closer to restitution
More Life Insurance News